Healthcare development Patients, product, price, people and policy should be the focus when developing healthcare p6 DAY 01 ARAB HEALTH daily dose MONDAY 26 JANUARY 2015 T h e o f f i c i a l da i ly n e w s pa p e r o f t h e ara b h e a lt h e x h i b i t i o n Welcome to Arab Health Exhibition & Congress 2015 Celebrating 40 years in healthcare W hen Arab Health began 40 years ago, it was as a small trade show held in tents on land right next to the old Intercontinental Hotel in Dubai, but as the healthcare industry has grown in the last four decades, so has the event, evolving into one of the world’s largest and most successful medical shows, reflecting the increasing importance of the Middle East as a global healthcare hub. Early exhibitors tended to specialise in hospital supplies, providing beds, bandages and scanning equipment, but over time the show has seen a huge increase in the participation of specialist groups from the region, as well as some of the world’s most famous teaching and training institutions, such as Cleveland Clinic and Johns Hopkins. For first generation exhibitors, the scale of opportunities to meet international medical groups and specialist companies was huge. Deals struck at the early events fed directly into the growth of the region’s healthcare infrastructure, supporting the construction and supply of a number of new hospitals built at the end of the 1970’s.The rapid expansion of Arab Health as an exhibition and congress followed suit and is now recognised as one of the most important global events in the healthcare calendar. Commenting at the event’s opening, Simon Page, Managing Director, Informa Life Sciences Exhibitions said: “Arab Health is at the heart of the region’s healthcare, and for a very valid reason. With the UAE healthcare market alone expanding by almost 100% last year and recent reports suggesting it is on a path to becoming a AED4bn industry by 2018, there is no better time or place to host one of the foremost healthcare trade events in the world.” Globally, healthcare services are struggling to cope with a growing number of health issues. The Gulf region in particular is facing its own fair share of challenges with population numbers rising 5% every year, and with residents living longer, the number of patients living with NCD’s or chronic illness is only going to increase. Justin Keen the English scholar, once explained; “No country can afford to run reactive illness services any longer”. The way we perceive health in the Gulf requires a cultural change, but also how care is delivered. Despite heavy investment into Continues on page 2 PTEN MUTATIONS AND AUTISM: THE SEARCH FOR INDIVIDUALISED TREATMENTS GETS UNDERWAY By: Thomas W. Frazier, PhD, Director, Cleveland Clinic Children’s Center for Autism N ew research out of Cleveland Clinic Children’s Center for Autism has focused on a genetic subgroup of children with autism spectrum disorder (ASD) (those with mutations of the PTEN gene) to identify a unique pattern of brain abnormalities and cognitive deficits. We are now building on these insights with new investigations that promise greater understanding of the biological mechanisms causing autism, and that ultimately may lead to individualised treatments. TURNING TO A GENETIC SUBGROUP FOR ANSWERS Disorders along the autism spectrum are frequently debilitating and lead to lifelong impairments in social interaction coupled with inflexible behaviour. Research has identified a strong genetic component to autism, but identifying effective treatments has been difficult due to high variability in the underlying biology. One approach to this problem is to study genetic subgroups of autism. Our group applied this strategy to individuals with PTEN mutations who also have autism (PTEN-ASD). My close colleague and scientific mentor, Charis Eng, MD, PhD, Chair of Cleveland Clinic’s Genomic Medicine Institute, identified the PTEN gene as a tumour suppressor. Dr Eng also noticed that parents with mutations in the PTEN gene were having a disproportionately high number of children with autism and very large heads, a feature consistent with brain overgrowth. Together, Dr Eng and I led a group that recruited 17 children with PTEN-ASD (mean age 11.5 years) and compared them to patients Story continues on page 4 PLEASE VISIT MASIMO Saeed Hall M-LNCS™ adult adhesive sensor Adult reusable sensor Stand S1H50 To learn more, visit www.masimo.co.uk © 2014 Masimo. All rights reserved. iSpO2 Rx is CE Marked. Not available in the US. Allows for use of any M-LNCS™ sensor, sold seperately. Smart mobile device sold separately. 8631C_Ad_Arab_Health_Daily_Dose_2015_iSpO2_Rx_63x267.indd 1 12/24/14 9:26 AM ARAB HEALTH daily dose Welcome to Arab Health Exhibition & Congress 2015 a new hospital infrastructure, the rise in noncommunicable and chronic diseases will not be stopped unless the focus changes to preventing and delaying health problems, rather than just treating the symptoms of a poorly system, hoping they will go away. Healthcare experts from both clinical and non-clinical specialities will be discussing these issues and many others as part of the Arab Health Congress. Regional and international speakers are coming together to deliver the highest quality Continuing Medical Education at 18 conferences to an audience of more than 10,000 delegates across the four days. The Congress, accredited by Cleveland Clinic, is growing every year, offering new conferences and topics on a broad spectrum of medical specialities and disciplines. The 1st Gulf Hypertension Conference is new this year, running over two days offering delegates keen to learn more about the extent of the disease and its impact in the region. Make sure to visit the conference registration area in the Al Wasl Foyer between halls 4 and 5 to find out more information about the congress and to book your place. To further cement Arab Health’s commitment RARE JOINT REPLACEMENT SURGERY PERFORMED IN DUBAI to further strengthen the expertise and know-how of healthcare professionals in the region, the new Future of Surgery Zone is a designated area in the Plaza Hall where specialists from the healthcare industry will conduct hands-on training sessions with the most sophisticated and up-to-date devices.Turn over to page 3 for the daily programme schedule. As tradition stands, Arab Health offers its visitors and delegates some fantastic promotional activities during the show. Remember to register to be in with the chance to win some great prizes, such as the new BMW 4 Series Gran Coupe, cash prizes and much more. HEALTH-PROMOTING NORDIC DIET REDUCES INFLAMMATORY GENE ACTIVITY IN ADIPOSE TISSUE Dr. Samih Tarabichi A F or only the third time in the Middle East and again by the same doctor, a surgery was performed recently to replace three joints simultaneously. Dr Samih Tarabichi, Director General of Burjeel Hospital for Advanced Surgery and Tarabichi’s Centre of Joint Surgery, and his team of two assistant surgeons carried out the surgery at Burjeel Hospital for advanced Surgery. The surgery went very well and lasted three hours, the same time normally used to only change a single joint.The patient is currently in rehabilitation. “The patient flew in to the UAE with major disabilities in both knee joints and her right hip caused by rheumatoid arthritis. Pre-operation tests showed that she was in a suitable condition to replace the three joints at the same time in order to speed up rehabilitation”, said Dr. Tarabichi, a celebrated orthopaedic surgeon who performs more than 800 joint replacement surgeries every year. The operation started with a bilateral total knee replacement simultaneously using subvastus To make the most of your visit this year, don’t forget to download the Arab Health mobile app from the website: http://arabhealthonline. com/mobileapp/. The app will help you navigate the expansive floor plans, browse through the thousands of exhibitors and products, and personalise your experience by creating your own favourites and notes, all from your own device. Thank you all for your support over the last 40 years - I wish you all the best for a successful and prosperous four days at Arab Health 2015. Elin Boyd Editor approach and Persona implants. The patient was moved to a lateral position and a right total hip replacement was done. “Once the operation was over, the patient stayed in hospital for a week to recover. We encouraged the patient to walk from day 2 onwards”, said Dr Tarabichi. “It was necessary for rehabilitation to start immediately post operation to ensure optimal movement of her joints. This rehabilitation programme will continue for two months.” The patient is progressing well and was discharged. She is now following up in our clinic and physiotherapy department. “We are pleased to have Dr Tarabichi on board, a doctor who is constantly looking for ways to further develop the field of orthopaedic joint surgery”, said Dr Shajjir Gaffar, CEO of Burjeel Hospital for Advanced Surgery in Dubai. “Constant progress in our respective fields is an important part of our commitment to ensuring the best medical care for the residents of the UAE.” Nordic study led by the Institute of Public Health and Clinical Nutrition at the University of Eastern Finland discovered that the health-promoting Nordic diet reduces the expression of inflammationassociated genes in subcutaneous adipose tissue. In overweight persons, the expression of these genes reduced without weight loss. To a certain extent, it’s believed that the adverse health effects of being overweight are caused by an inflammatory state in adipose tissue. The results were published in American Journal of Clinical Nutrition. Obesity is associated with problems in sugar and lipid metabolism as well as with atherosclerosis, and these may be caused by a low-grade inflammatory state resulting from disturbed adipose tissue function. Long-term research into the role of diet in the function of adipose tissue genes and inflammatory state remains scarce. This newly published study was part of the Nordic SYSDIET Study. The objective was to find out whether the health-promoting Nordic diet affects the expression of genes in adipose tissue without weight loss. The study participants were middle-aged men and women exhibiting at least two characteristics of metabolic syndrome, such as elevated blood pressure or fasting blood sugar levels, abnormal blood lipid values, or at least slightly overweight. For a period of 18-24 weeks, half of the study participants followed the health-promoting Nordic diet consisting of whole grain products, vegetables, root vegetables, berries, fruit, low-fat dairy products, rapeseed oil and three servings of fish per week. The control group consumed low-fibre grain products, butter-based spreads, Vu LED SURGICAL LIGHT and had a limited intake of fish.The participants were asked to maintain their body weight unchanged during the intervention, and no significant weight changes occurred during the study period. Samples of the study participants’ adipose tissue were taken at the beginning and end of the study, and a transcriptomics analysis was performed in order to study the expression of genes. Differences in the function of as many as 128 different genes were observed in the adipose tissue of the health-promoting Nordic diet group and the control group. In the healthpromoting Nordic diet group, the expression of several inflammation-associated genes was lower than in the control group. According to the study researchers, the fact that diet can be used to affect the function of inflammationassociated genes without weight loss is significant. The study sheds further light on the significance of diet in the healing of low-grade inflammation, which is associated with several chronic diseases. Visit us at Booth 4B05 CROSS FOCUS TECHNOLOGY (CFT) enables the LED’s to move independently of each other while adjusting the pattern size. CFT allows the Vu to provide consistent output on both the large and small patterns. 2 NUVO-strip ad-horiz.indd 1 facebook.com/arabhealth A member of the Medical Illumination International Group V Series Surgical Tables VistOR MS LED 120,000 lux Navigator Equipment Management 5368 Kuhl Road • Erie, PA 16510-4703 (814) 899-4220 • Fax: (814) 899-1410 (800) 663-1152 www.nuvosurgical.com 12/9/14 12:52 PM MONDAY 26 January 2015 Today at a glance Arab Health 2015 Congress Conference ROOM Location Start Time Finish Total Radiology Al Multaqua Ballroom Between Halls 4 & 5 10.20 17.00 Lab Mgmt - (MEDLAB) Sk Maktoum Hall - Part B\C Shk Maktoum Hall 10.00 17.40 Diabetes Shk Rashid Hall - Part C Shk Rashid Hall 09.50 17.30 Paediatrics Shk Rashid Hall - Part D Shk Rashid Hall 10.00 18.00 Hypertension Ajman D/Fujairah A Above Hall 7 08.15 18.30 Public Health Dubai C&D Above Shk Maktoum Hall 09:20 18:00 Urology Abu Dhabi A First floor opposite Hall 5 09.45 17.40 Quality Mgmt Abu Dhabi B First floor opposite Hall 5 10.00 18:00 Orthopaedics Al Ain J & K Above Hall 4 08.00 18.00 Exhibitor’s Dinner 19.00 at the Habtoor Grand Hotel, Dubai Exhibitors can buy tickets today Organiser’s Office outside Hall 4. Tickets are AED100/US$25. Transport to the Habtoor Grand Hotel is available after the show. Arab Health Daily Dose The Arab Health Daily Dose is the official newspaper of the Arab Health Exhibition & Congress. Distributed Monday 26 January-Thursday 29 January 2015. DIRECTOR - PUBLICATIONS Joseph Chackola [email protected] EDITOR Elin Boyd [email protected] SALES MANAGER - PRINT & ONLINE Waseem Ashraf [email protected] SENIOR GRAPHIC DESIGNER Mark Walls [email protected] PRINTED BY Zabeel Printing Press www.zppdubai.ae The Arab Health Daily Dose is owned and distributed by Informa Exhibition Life Sciences, Floor 19, World Trade Centre Tower, Dubai, UAE. All images © Shutterstock.com unless otherwise specified. This publication may not be reproduced or transmitted in any form in whole or part without the written consent of the owners. For more information on Informa Exhibitions Life Sciences publications, please visit www.arabhealthmagazine.com To s pea MEDIA k th e dur Hea ing team l A t the h, vi rab loc press sit us i a C, a ted inofficen bov Al A e Ha i ll 3 n Download the free Arab Health mobile app DOWNLOAD NOW arabhealthonline.com/mobileapp FUTURE OF SURGERY Arab Health 2015 is featuring the newly launched Future of Surgery Zone, which consists of a designated area where top specialists in the healthcare sector are running hands-on training sessions on the most sophisticated and up-to-date devices and technology. Attend absolutely free! Visit the Future of Surgery Zone in Plaza Hall every day during Arab Health. HIGHLIGHTS DAY 1 programme Innovation hub seminars (see schedule below) Interactive touchscreen displays to plan your Future of Surgery experience A rare 1867 edition of medical journal, The Lancet A glance at the history of surgery Meet one on one with experts in the field See the 3D printed baby heart that allowed doctors from New York- Presbyterian Morgan Stanley’s Children’s Hospital better plan ahead of surgery on a very complex and unique heart malformation DAY COMPANY TOPIC SPEAKER/ORGANISER 11.00 Depuy Joints Stability in motion Ahmad Kartoumah / Ahmed Ali 11.30 Primal Pictures 3D human anatomy in real-time 12.00 Ethicon Biosurgery Advances in Surgical Haemostasis – Pipe line presentation R&D J&J USA 14.00 Health Economics Healthcare cost drivers and medical technology DHA/DAMAN 15.00 Primal Pictures Orthopaedic surgery; a 3D resource for a 3D subject 16.00 Ethicon Bariatrics Science of tissue management – Bariatric procedures MARKETING TEAM SELFIE COMPETITION WIN a Samsung Tweet your selﬁe to @arab_health along with #arabhealth Galaxy Tab3 Upload your images at arabhealthonline.com/competition #arabhealth @arab_health 3 ARAB HEALTH daily dose AMERICAN HOSPITAL DUBAI LAUNCHES FIRST PRIMARY CARE CLINIC IN DUBAI MEDIA CITY, TO STAY CLOSE TO THE HEART OF THE COMMUNITY A merican Hospital Dubai, one of the leading pioneers of private healthcare in the Middle East, is set to launch its first community clinic off-campus serving the growing population in Dubai’s new residential communities and business free zones. The new clinic, strategically located in Dubai Media City, will offer the same quality of care for all members of the family through a dedicated team from the American Hospital Dubai, which has served local and regional patients from its main campus since opening in 1996. The hospital is announcing the new clinic today at Arab Health 2015 where the hospital is a Platinum Sponsor. The hospital’s new Dubai Media City Clinic (DMCC) will begin welcoming patients from 2 February 2015. The American Hospital Dubai’s new Dubai Media City Clinic is based on the ground floor of the Business Central Tower, close to Sheikh Zayed Road, offering a range of primary care services for all members of the family, including paediatrics and obstetrics and gynaecology, as well as imaging (radiology, ultrasound, mammography), laboratory (phlebotomy, draw station) and patient-only pharmacy. The 1,420m2 clinic will have a dedicated physician team supported by an on-site nursing team and support staff. The DMCC will offer close and convenient access to high quality primary care for patients in the nearby residential areas and business free zones, as well as access to the American Hospital Dubai’s full range of speciality services and diagnostics at the main hospital campus.15 allocated parking spaces and long hours of operation (9am-9pm, seven days) add to the convenience. Electronic Medical Records will be shared between the clinic and hospital campus, for ease and speed of information sharing. Commenting on the new clinic, American Hospital Dubai’s CEO, Peter Makowski, said: “American Hospital Dubai has always been a pioneer in private healthcare and our new Dubai Media City Clinic continues this tradition. This major development reflects our commitment to continue to serve the community of Dubai within the hear t of the community, wherever that may be. Our plan is to take our established quality of care into the community to meet the evolving needs of patients in the new neighbourhoods of Dubai. This is the first in a series of primary care clinics that we plan to open in Dubai, as satellites to our growing hospital campus, all delivering the same quality of care with exper t teams of board cer tified specialists.” NUCLEAR IMAGING MARKET TO STAGNATE IN US WHILE ASIAPACIFIC SEES STRONG GROWTH BY 2020, SAYS GLOBALDATA T he global market for nuclear imaging equipment, which covers Positron Emission Tomography (PET) and Single-Photon Emission Computed Tomography (SPECT) systems, will expand from US$1.83bn in 2013, at a modest Compound Annual Growth Rate (CAGR) of 3.3%, to reach US$2.2bn by 2020, says research and consulting firm GlobalData. The company’s latest repor t states that while the US market will remain steady at around US$1.15bn throughout the forecast period, the country will see its global share fall from 69% in 2013 to 53% by 2020. Meanwhile, the Asia-Pacific (APAC) region will see its share rise from 16% to 29% over the same time frame. According to Andrew S. Thompson, PhD, GlobalData’s Senior Analyst covering Medical Devices, a period of rapid increase in US procedures, particularly using PET, has led to measures to decrease the number of procedures that can be reimbursed, therefore reducing the demand for nuclear imaging systems. Thompson explains: “The economic downturn has been a continued concern within the entire diagnostic imaging space, and the high cost of nuclear imaging equipment and procedures has made this market more susceptible to the downturn. US nuclear imaging market growth is heavily dependent on the replacement of existing systems because the capacity for new installations is limited. “As the US economy recovers, it can be expected that the equipment will be replaced. However, key opinion leaders interviewed by GlobalData reported that not all equipment is replaced at the end of the average product lifecycle, which will negatively impact sales.” While the US market is likely to remain static, with a CAGR of only 0.08% from 2014 to 2020, APAC economies, especially China and Japan, will continue to provide immense opportunities for increasing sales within the global nuclear imaging arena. Thompson continues: “Japan will see the fastest growth over the forecast period, with its market value more than doubling from US$191.3mn in 2013 to US$392.1mn by 2020. “In global terms, the rising prevalence of disease, along with an ageing and growing population, will act as major drivers of increased nuclear imaging use during the forecast period.” PTEN MUTATIONS AND AUTISM: THE SEARCH FOR INDIVIDUALISED TREATMENTS GETS UNDERWAY Continued from cover. with autism with no known genetic cause and to healthy controls. The primary goal was to identify specific patterns of brain abnormalities and thinking skills unique to PTEN-ASD.The secondary goal was to determine whether these changes are linked to the molecular effects of PTEN mutations. FINDINGS: USEFUL CLINICAL SIGNALS EMERGE Our study found that patients with PTEN-ASD had overgrowth of the white matter connections as well as spots where white matter development was clearly abnormal. These brain changes correlated with cognitive problems, such as reductions in information processing speed and memory, as well as motor difficulties in the PTEN-ASD group relative to both other study groups. These findings enabled us to determine that reduction in the PTEN protein drives brain overgrowth and white matter abnormalities that, in turn, drive these patients’ cognitive and behavioural impairment. At a practical level, these data suggest that any child presenting with large head size and developmental or cognitive delays should receive genetic counselling and possible testing for a PTEN mutation. Such testing is particularly important because individuals with PTEN-ASD may have increased cancer risks due to the role of PTEN as a tumour suppressor and regulator of cell growth and proliferation. Our findings also suggest that therapists treating patients with PTEN-ASD should speak slowly and clearly, with frequent repetition and attention questions, to ensure that children understand the information being communicated. Given the high rate of motor difficulties seen in patients with PTEN-ASD, patients also should be regularly referred for occupational and, in many cases, physical therapy. OTHER PROTEINS APPARENTLY NOT IMPLICATED Interestingly, we did not find that other proteins related to PTEN were abnormal, suggesting that PTEN mutations cause reductions in PTEN protein levels but do not seem to cause changes in the typical PTEN biological pathways. This may indicate that reductions in PTEN protein levels are working through other mechanisms, such as interactions with mitochondrial or metabolic pathways or other noncanonical biological routes. IN THE WORKS: A LONGITUDINAL STUDY AND MEDICATION TRIAL Future research is needed to pin down the exact molecular effects of PTEN protein loss and develop additional treatment targets. However, based on the low PTEN protein levels observed in this study, Dr Eng and I have received funding as part of a consortium examining rare genetic causes of autism, to longitudinally follow patients with PTEN-ASD over two years and begin a medication trial. The latter is especially exciting because it was designed based on knowledge of PTEN and associated pathways and would represent one of the first attempts to develop an individualised gene-based treatment approach for children with autism. We hope to build on the findings reported here by using processing speed, memory and brain white matter changes as outcomes to provide more-sensitive treatment targets than those used in typical medication trials focused on autism symptoms or other behavioural aspects that often require long periods for changes to be detectable. Ultimately, we believe this study and the planned follow-up research are just representing the beginning of a new paradigm for autism research: Find the gene, or set of genes, causing autism, comprehensively study and follow patients with those genetic changes, and use the knowledge gained to develop individualised treatments. Cleveland Clinic is a sponsor of Arab Health 2015. Join Dr Frazier and other Cleveland Clinic Children’s specialists as they present at the 8th Middle East Paediatrics Conference. REFERENCES References available on request ([email protected] informa.com) Visit the UK Pavilions for the best in Medical Technologies Zabeel Hall UK Medical Technologies Pavilion | Sheikh Rashid Hall UK Laboratory Technologies Pavilion Don’t miss the UK Pavilion Surgical Simulation Demonstrations Visit the ABHI Stand Z1D30 4 3828 ABHI Strip Ad 63x267.indd 1 facebook.com/arabhealth 19/01/2015 12:33 MONDAY 26 January 2015 Q&A Lord Stephen Carter CBE Group Chief Executive, Informa plc Stephen Carter is the Group Chief Executive of Informa PLC, organisers of Arab Health and one of the world’s leading academic publishing, information, knowledge and exhibitions businesses, with a career having spanned both the Public and Private sectors. We got a moment with Lord Carter ahead of Arab Health to discuss Informa PLC’s role in the support of continuing education in the life sciences industry, both regionally and internationally. Q. How does Informa support the life sciences industry in the Middle East and beyond? Informa Life Sciences is the leading global information partner across the healthcare and pharmaceutical sectors. With a market capitalisation of US$5bn, and more than 8,000 employees in 150 offices in 40 countries, Informa provides a comprehensive range of products and services in this sector from academic books and journals, trade magazines, deep-knowledge databases, market intelligence, consulting and event platforms. Each year, across the group, we bring together approximately 1.1 million professionals from every corner of every continent, all looking to meet, network and do business. The Life Sciences Global Exhibitions division comprises of more than 20 exhibitions covering the Middle Eastern, African, Asian and European markets. Our academic publishing produces more than 20,000 publications and more than 5,000 titles in life sciences and medicine. In addition to traditional print publications, Informa provides access to more than 8,000 titles through its award-winning platform CRCnetBASE. Our Business Intelligence produces a comprehensive range of market leading news, insights, data and analysis for business and research professionals within the pharmaceutical and biotech industries.We offer structured databases, subscriptionbased services, real-time news, research and businesscritical information creating business advantage. Informa’s Knowledge and Networking division delivers a diverse portfolio of conferences and partnering events covers the pharmaceutical, medical devices, biotechnology, diagnostics, fine chemicals, agrochemicals, veterinary medicine and healthcare arenas including market access, payers and providers. Q. Arab Health is Informa’s flagship healthcare event. How do you see the event developing in the coming years? The future of exhibitions now lies in our ability to provide a platform that offers more than just business networking. All medical professionals have one thing globe has taught us to never underestimate the power of solid partnerships or mergers. For multinationals looking to establish themselves as a big player in an emerging market, PPPs are often the most direct way of solidifying their brand identity in that particular territory. Local players are more likely to understand the local business climate and often have existing relationships with key government departments; something that multination’s often struggle to establish without the endorsement of a local partner. By acknowledging the current trends in the market and identifying the niche opportunities available for our exhibitors, Informa Life Sciences Exhibitions continues to be the preferred platform for our customers to market their products, garner intelligence, debate industry issues and network with each other. in common: Staying committed to life-long learning in order to provide patients with the best possible care. With a constant stream of new data from clinical trials, new therapies, technology and treatments constantly emerging, it is critical to stay current in the real-world application of evidence-based medicine. Each year, the Arab Health Scientific Committee will assess the specific requirements for the region and will develop conferences specifically designed to cater to the requirements of the healthcare industry in the Middle East. Q: Are you optimistic about the future of the healthcare exhibitions industry? Retaining our competitive edge in the market and appealing to our target audience has meant that it has been necessary to stay up-to-date with market fluctuations and to identify new trends in the global healthcare industry. We view the healthcare market in the MENA region to be one of the most sought after markets for healthcare investments in the world. The healthcare market has experienced stellar growth over the last decade and is projected to maintain its momentum driven by a multitude of factors including demographic growth, high and expanding medical needs, more active investments by governments and private sector in the healthcare market, development of social welfare systems, introduction of private insurance market, increased healthcare regulation, introduction of compulsory health insurance in a number of countries; to name a few. Our experience running B2B exhibitions across the LEARN MORE Meet the team at stand S2E80 in Saeed Hall 2 during Arab Health and learn about all Informa services, books and events. Why should I go? Visitors can expect to learn from experts about the latest devices and methods, including; • Minimally invasive devices and techniques • Robotics • Bloodless surgeries • Laser applications • Implantable devices and systems • Imaging and image guiding technologies and much more… What does the future of surgery look like? Find out by visiting the Future of Surgery Zone in the Plaza Hall today Who should attend? The Future of Surgery Zone is not just for surgeons but is open to anyone who’s interested in knowing what the future entails for surgery. What is the Future of Surgery Zone? Who will be there? The Future of Surgery Zone is an interactive hub in Plaza Hall which gives you the opportunity to learn about and experience new and exciting surgical methods and technologies. This is an opportunity to meet with specialists from the leading companies listed below. They will be showcasing their latest products and will be available all day to answer any questions you may have. Participating companies: Our futuristic hologram doctor will be there to welcome you to the Plaza Hall so be sure to stop by and say hello. #arabhealth @arab_health 5 ARAB HEALTH daily dose HEALTHCARE DEVELOPMENT DEPENDS ON MASTERING THE FIVE P’S By: Marwan Abedin, Chief Executive Officer, Dubai Healthcare City I n today’s fast-paced world, healthcare systems are trying, in most cases, to remain relevant. In the UAE, where the environment is characteriaed by increased population, robust infrastructure, growing prevalence of lifestyle diseases and an increased flow of tourists, the healthcare sector is moving at an accelerated pace. This is further reinforced by policylevel changes like mandatory insurance and improved healthcare delivery aimed at wellness and preventive care. To keep up with this pace, I believe we need to focus on the five P’s of healthcare development. These are: Patients - A formidable challenge for the UAE is to reverse the outbound medical tourism trend. DHCC is improving healthcare provision for residents and overseas patients who need specialist care. As of December 2014, over a million patient visits were recorded, 15% of patients were medical tourists. We hope to push this figure higher through our affiliations with global medical tourism facilitators, linking patients to doctors and offer medical tourism packages including flights, visas and accommodation for patients and their families, and through collaborative efforts with our stakeholders in the government. People - We need to address the shortage of local healthcare talent in both the nursing and physician professions. Towards education and research, our dedicated academic complex the Mohammed Bin Rashid Academic Medical Center (MBR-AMC) is building capacity and advancing medical education in the region. For example, the Khalaf Ahmad Al 6 Habtoor Medical Simulation Center (KHMSC) within MBR-AMC trained more than 1,400 multidisciplinary healthcare professionals in H1 2014. We have also announced the launch of the Mohammed Bin Rashid University of Medicine and Health Sciences, which will offer undergraduate and postgraduate programmes. Product – Healthcare services can be compared to a product.To be competitive, it must stay relevant to meet market demands. In other words, innovation to improve healthcare delivery; we achieve this through strategic partnerships. Price – We expect the phased implementation of mandatory health insurance in Dubai and the regulation of healthcare insurance premiums to ensure market stability and sustainability. Policy – When healthcare is no longer confined to geographical borders, a healthcare system has to meet the challenges of policy and regulation. Factors of accreditation, medical visas, and follow-up care, amongst others are all crucial. If we manage to include all P’s in a well thought-out formula that also takes into consideration the latest trends in technology, I foresee tremendous growth for the healthcare sector in the UAE. Marwan Abedin, Chief Executive Officer, Dubai Healthcare City facebook.com/arabhealth MINNESOTA INTERNATIONAL MEDICINE SPONSORS US PAVILION RIBBON CUTTING CEREMONY M innesota International Medicine, an international patient care management organisation, operating in the Twin Cities, Minnesota, USA, are sponsoring the official opening event for the US Pavilion for the second year in a row. The honourable US Ambassador Barbara A. Leaf will present the US Pavilion ribbon cutting at 11:30 today. Minnesota International Medicine (MIM) serves the global community by facilitating treatment for international patients in the United States and assisting medical communities abroad. By building strong connections between healthcare communities in all parts of the world, MIM strives to create an environment that will focus on improving healthcare for patients everywhere. MIM is the international patient centre for top ranked medical providers with diverse range of specialities in the Twin Cities. International patients travelling to the US have access to resources that will give them a comfortable and comprehensive treatment experience. AT THE SHOW To learn more about MIM and their services, you can visit their team at Arab Health, stand 1E19 in the US Pavilion, or online at www.mnimed.com and follow our conference experience on Twitter @mnimed MONDAY 26 January 2015 #arabhealth @arab_health 7 ARAB HEALTH daily dose GE: INVESTING IN INNOVATION TO TACKLE THE CHALLENGES OF MIDDLE EAST HEALTHCARE B y 2030, almost 80% of deaths in the Middle East will result from non-communicable diseases (NCDs), such as cardiovascular disease (CVD) or cancer. The high prevalence of unhealthy diets, smoking and lack of physical exercise, a direct result of urbanisation and rising per capita income, are big contributing factors. Maher Abouzeid, President and CEO of GE Healthcare for Turkey and the Middle East, said: “The increasing incidence of lifestyle diseases and population growth in the GCC has caused healthcare expenditure to increase by 10% per year over the last five years. Total healthcare expenditure is now expected to be more than US$130bn in 2018. This poses a real challenge to governments and healthcare systems in the region” Investing 5-6% of revenues back into R&D annually, GE remains focused on being a leader in technology and innovation. Moreover, the scale and rate of innovation is set to significantly transform the sector in the next 10 years as healthcare continues to industrialise. “To help cater for the increase in NCDs and to improve access to quality and affordable healthcare, there is greater emphasis from governments to partner with companies that can provide system-wide solutions that deliver better clinical and patient outcomes, one of the core priorities of GE Healthcare”, added Abouzeid. “It’s the 40th Arab Health, and GE Healthcare has more than 40 years of operations in the region. Over these past four decades, GE has been focused on helping to deliver customer-oriented offerings that enable caregivers to strengthen operational efficiency, enhance diagnostic competencies, and potentially reduce healthcare expenditure through earlier diagnosis, better tracking of disease progression and personalized medicine. Many of these offerings are today at work, helping our customers and partners bring better care to patients across the Arab world.” GE Healthcare has a history of pioneering innovation. It was the first healthcare provider to produce the world’s first x-ray fluoroscopy scan, the first commercially available mammography technology, the world’s first high definition CT scanner and more recently, the first to make available a portable 4D foetal ultrasound. GE will continue this tradition at Arab Health by launching several of its latest technologies developed to improve healthcare in the Middle East. One such innovation being introduced is the SIGNA Pioneer Magnetic Resonance Imaging (MRI) scanner. With MRI scans, radiologists typically have to take several images, each one with a different focus, to get the best look inside a patient. This is a time and resource consuming process, but the Image © GE Healthcare 510(k) pending SIGNA Pioneer* comes with MAGiC (Magnetic Resonance Image Compilation), a software platform that can actually generate multiple contrasts from a single scan. It’s like changing the focus of a previously taken photograph without having to take another one. This ‘one-and-done’ imaging method means radiologists can now see one more patient per hour, every hour, every day, helping cater for increased demand. GE hopes to continue its innovation in the field of mother-and-child care in the region with the Voluson E10 ultrasound, allowing clinicians to view babies in the womb with amazing detail. The system uses the same principles of ultrasound that have been used for decades, but the differentiator is the software. The image processing powers of the Voluson E10 can be used for more than superficial look at the foetus. The technology can be used to obtain images of the baby’s blood vessels, heart, brain and other organs that show depth and structure in a way that helps provide the tiny details desired. This is especially important in the first trimester, where it is important to keep track of the baby’s growth. GE Healthcare is one of the largest participants at Arab Health, with a stand larger than 525m2 in area, which has been designed to mirror the hospital environment that customers encounter every day, while providing insight on the innovations that GE brings to each care setting. Also this year, GE Healthcare is introducing for the first time the ‘GE Arab Health’ mobile app (available on iTunes) to help visitors navigate their way through the new technologies GE is presenting at Arab Health 2015. The app uses geo-targeting to deliver content about GE’s products and solutions to the mobile app user based on his/her location on the stand. As Platinum Sponsor of the event, GE Healthcare is also extending its support to the show conferences on Big Data, Leaders in Healthcare, Biomed Leaders and Radiology. Visit GE Healthcare’s pavilion at Sheikh Saeed Hall, stand no S3B10. REFERENCES References available on request ([email protected] informa.com) *SIGNA Pioneer and MAGiC are 510(k) pending at FDA. MASIMO’S ISPO2™ RX PULSE OXIMETER FOR MOBILE DEVICES T he Masimo iSpO2TM Rx Pulse Oximeter for Android™ and iOS devices offers clinicians the power of Masimo SET® Measure-through Motion and Low Perfusion™ Pulse Oximetry in the palm of their hands, on their smart phones and tablets. iSpO2 Rx provides accurate spot-check and short-term assessment of oxygen saturation (SpO2), pulse rate (PR), and perfusion index (PI). iSpO2 Rx is ideal for: Emergency workers who want the convenience and availability of pulse oximetry at all times when other Masimo handheld oximetry solutions are not at hand Travelling respiratory therapists and physicians who require convenient and portable solutions Image © Masimo 8 facebook.com/arabhealth Many patients under the care of a physician for chronic obstructive pulmonary diseases (COPD) such as emphysema, chronic bronchitis, and bronchiectasis, may benefit from the use of a pulse oximeter for spot checks Patients under the care of a physician may use pulse oximetry to assess the severity of an asthma attack to help determine if a doctor or emergency room visit is warranted. Compact and intuitive operation with a familiar touch-screen interface, iSpO2 Rx comes with an integrated finger pulse oximetry sensor or an optional M-LNCS TM connector, which allows the iSpO2 Rx to be used with more than 20 Masimo SET® pulse oximetry sensors. iSpO2 Rx utilises the same Masimo SET® Measure-through Motion and Low Perfusion™ pulse oximetry technology proven by more than 100 independent and objective studies and used on more than 100 million patients a year in leading hospitals worldwide, including eight of the top 10 on the U.S. News & World Report Best Hospitals Honor Roll (20142015). Masimo SET® pulse oximetry has been shown to help clinicians reduce ventilator weaning time and arterial blood gas measurements in the ICU, and save lives and costs while reducing rapid response activations and ICU transfers on the general floor. iSpO2 Rx for select Android devices and iPad, iPhone, and iPod touch also features a downloadable and upgradeable iSpO2 Rx App, ensuring clinicians have the latest mobile medical technologies at their fingertips at all times. iSpO2 Rx, with real-time display of pleth waveform with signal IQ for low measurement confidence, can store and email up to 12 hours of measurement history in a global standard .CSV file format. iSpO2 Rx with the M-LNCS connector is compatible with Masimo adhesive and reusable sensors for paediatric and adult use. MORE INFO References available on request ([email protected] informa.com) Available for purchase outside the US, the iSpO2 Rx includes cable and sensor module (M-LNCS version excluded), carrying case, and owner’s manual. Android is a trademark of Google Inc. iPad, iPhone, and iPod touch are trademarks of Apple Inc., registered in the US and other countries. MONDAY 26 January 2015 THE FUTURE OF HEALTHCARE EMERGENCY MANAGEMENT: LESSONS LEARNED FROM THE EBOLA OUTBREAK OF 2014 By: Thomas Omogi, CEO, EMT-P, RN, Infection Control Specialist, EFP Tactical Medical Group M ass transportation and international trade is shrinking the globe. Like never before, people can travel across the planet to work and interact with those from different countries. These global interactions improve the economies of impoverished nations, shift international relations, and influence political policies. This widespread interaction between people of many countries also makes it possible for infectious diseases to leap from one continent to another in a matter of hours, as it did in the most current outbreak of Ebola virus disease (EVD). Global trade will likely spur international travel in the future, dramatically raising the risk for infectious diseases. Without capable emergency healthcare management on the part of individual nations and international governing bodies, catastrophic pandemics of the future will continue to cross national boundaries and fly across oceans. One of the best ways to develop a capable emergency healthcare management plan for the future is to learn from the past. Lessons from the 2014 Ebola outbreak certainly have a lot to teach. LISTEN TO THE EXPERTS Doctors without Borders sounded the alarm but nobody listened, when, in April of 2014, the group issued warnings that the Ebola outbreak was getting out of control. This sparked a debate between the charity organisation and a spokesperson for WHO, who insisted they had the outbreak under control. Dr Peter Piot, the co-discoverer of the Ebola virus said that WHO acted too slowly, largely because of its African office. THINK GLOBALLY, TRAIN LOCALLY The CDC has continually fumbled its efforts to prepare healthcare workers for a possible Ebola outbreak. Reports of the outbreak had filtered into US news for several months before the virus ever hit American soil. This gave the CDC plenty of time to prepare healthcare workers to identify Ebola and safely treat patients with EVD, but the agency simply did not seize the opportunity. Taking their cue from the CDC, local hospitals did not adequately prepare healthcare workers to recognise and deal with the potential threat. for an ambulance. By this time, the other individuals in Duncan’s household had been in contact with dozens of people, potentially spreading the deadly disease to an untold number of people. Doctors finally admitted Duncan on September 28 and diagnosed him with Ebola on September 30. Several nurses and laboratory technicians worked with Duncan directly and had contact with his body fluids. During Duncan’s visits to the emergency department and the first hours of admission to the hospital, nurses and other caregivers did not employ anything other than the standard infection control protocol. Consequently, several healthcare workers were exposed to the virus and a few came down with the disease. Meanwhile, officials quarantined Duncan’s roommates in the apartment, along with the man’s soiled sheets and clothing. Fortunately, the people in the apartment sealed off Duncan’s belongings in a bedroom and did not contract the virus. While the quarantine worked to prevent the potential spread of Ebola outside the apartment, sealing people in small quarters with Ebola-infected material put the citizens in harm’s way. This scenario has occurred countless times in the three countries most affected by the outbreak, with a cycle of bad protocol and mistakes perpetuating the spread of the virus. Patients often deny exposure because they are afraid dying or, if they live, worried that their community will ostracise them. Healthcare workers miss important signs by asking the wrong questions or ignoring evidence. Hospitals and other healthcare institutions skimp on training and equipment until the infectious disease that is running rampant in other countries actually strikes in their own neighbourhood, instead of paying attention to the pandemics occurring on foreign soil and creating a protocol to respond to the threat ahead of time. Governing bodies impose quarantines improperly, endangering lives rather than protecting them. TREAT EBOLA AS A VIRUS, NOT AS A POLITICAL PAWN The document also pointed out that the regional heads of WHO in the affected areas were politically motivated appointments. Dr Luis Sambo was the WHO regional director for Africa; he did not answer to the agency’s chief in Geneva, Dr Margaret Chan. The hierarchy is the same for WHO’s other regional directors, including those in the Americas, Europe, Eastern Mediterranean, Southeast Asia and the Western Pacific, where these directors are elected by their regions and are not accountable to the main office in Geneva. “Nearly everyone involved in the outbreak response failed to see some fairly plain writing on the wall”, WHO said in the document. “A perfect storm was brewing, ready to burst open in full force.” TREAT EACH OUTBREAK AS AN INDIVIDUAL CRISIS There are some significant differences in the two EVB outbreaks. The first occurred in remote villages in Central Africa. The more recent outbreak occurred in West Africa, primarily in urban areas but cases appeared in rural areas as well. EVB first appeared in 1976, erupting in two simultaneous outbreaks. The first cases of EBV occurred in Nzara, Sudan, and then spread to Maridi, Tembura, and Juba. The second outbreak happened in Yambuku, Democratic Republic of Congo, a small village located near the Ebola River from which the virus derived its name. Numerous smaller outbreaks have flared up throughout the years. While EVD inflicted an unusually high mortality rate, healthcare workers were able to contain, control and eventually quell outbreaks. It seemed scientists could control Ebola and confidence often gave way to complacency. The current outbreak in West Africa is the largest and most complex outbreak, with more cases of the disease and deaths than all the other outbreaks combined. The most recent outbreak is also different because it spread between countries. In an October 2014 draft document obtained by Associated Press, WHO acknowledged its bungled attempts to control the outbreak. Authors of the document say that experts should have recognised that traditional methods for containing infectious diseases would not work in the outbreak regions because of broken health systems and porous borders. THE FUTURE OF HEALTHCARE MANAGEMENT Healthcare providers can apply the lessons learned from the Ebola crisis to develop a sound and robust healthcare system that works as well globally as it does locally. To provide proficient healthcare management to control future EVD outbreaks, we must apply a package of interventions that includes cause management, surveillance and contract tracing, adequate laboratory services, and safe burials. One of the most important components of the intervention package is social mobilisation. Community engagement, especially on the local level, is essential to controlling outbreaks for many reasons, including illiteracy and mistrust of outsiders. Volunteers go to marketplaces, bus stations and other busy places to disseminate information via loudspeaker, answer questions, and sometimes distribute soap and bottles of chlorine. ADHERE TO PROTOCOL Future emergency healthcare management relies on doctors and nurses who practice good medicine with a strict adherence to protocol. This did not always happen during the 2014 outbreak. Thomas Eric Duncan presented a 39.4°C fever at Texas Health Presbyterian Hospital on September 26 after travelling to West Africa, according to nurse records. The nurse also noted that Duncan denied exposure to a sick person during his trip, which proved to be untrue. The attending physician noted the patient was ‘negative for fever and chills’ and discharged the patient to home with antibiotics. After spending several days in an apartment with four other people, Duncan’s condition worsened and concerned family members called #arabhealth @arab_health 9 ARAB HEALTH daily dose ROCHE DIAGNOSTICS’ LATEST LABORATORY SOLUTIONS UNVEILED AT ARAB HEALTH Newest launches on display for the first time in the Middle East S ince the establishment of its hub in the UAE three years ago, Roche Diagnostics Middle East has been providing continuous service, support and expertise to the regional in vitro diagnostics industry. Operating from this location, allows Roche Diagnostics Middle East to fulfill its commitment to healthcare professionals, bringing them closer to the solutions and services that meet their needs.This year, at the 40th Arab Health Exhibition, healthcare professionals can have a first-hand look at the latest innovations from Roche Diagnostics and explore a complete stateof-the-art laboratory setup. At its stand this year, the newest technologies in laboratory automation, histopathology and coagulation are launched and on display, such as the cobas® 8100, cobas t 411, and the VENTANA HE 600. For the first time in the Middle East, Roche will display the cobas® 8100 automated workflow series, a total lab automation solution that supports Image © Roche Diagnostics central laboratories. This cutting-edge solution, like others from cobas®, is designed to help healthcare professionals deliver smooth, efficient in vitro diagnostics service, with comprehensive technology including pre-analytics, analytics and post-analytics. Whether a laboratory has high throughput, short turnaround time or both, the cobas® 8100 can fulfill the laboratory’s changing needs, allowing faster and more efficient workflow. The solution provides real value using its 3D intelligent bi-directional transportation system with STAT prioritisation, sample integrity and tracking, and emergency sample handling. Furthermore, the cobas® 8100 is designed with connectivity options for a range of instruments, providing flexibility to grow it as needed. This year, Roche Diagnostics will also unveil its entry into laboratory coagulation with the cobas t 411. This coagulation analyzer begins a new era for Roche in the world of coagulation, delivering safety, efficiency and productivity. It is designed to allow maximum flexibility for laboratories with low to medium throughput. Best-in-class reagent, sample and cuvette storage capacity means the analyzer is not only easy to use but also requires minimal interaction during daily use. The cobas t 411 analyzer is designed with a unique set of enhanced safety features to ensure robust and high quality patient results, every time. Other innovative features in the solution include: automated, multi-vendor cap-piercing, maximised reagent utilisation and integrated barcode scanning for samples and reagents. As Roche Diagnostics shares the vision of healthcare professionals for exceptional patient care and safety, the booth will also exhibit the latest solutions for histopathology laboratories, including the VENTANA HE 600 system. As a leading player, Roche provided the first fully automated H&E instrument ‘Symphony’, and now the VENTANA HE 600 system, takes the technology to the next step. With the VENTANA HE 600 system, laboratories can rely on fully automated, consistent high quality H&E staining with no patient cross contamination in a simpler and more cost-effective way. The system provides from its ancestor improved instrument reliability, higher throughput of 200 slides/hour, no alcohol usage and reduced reagent volumes for lower waste generation. HE600 takes the next step towards full automation in Hematoxylin and Eosin staining. With innovations such as these, Roche Diagnostics has maintained its position as a world leader in in vitro diagnostics. With its high standard technology and continuous innovation, Roche Diagnostics’ solutions deliver quality and reliability for more accurate results. Roche Diagnostics Middle East is dedicated to equip healthcare professionals with better diagnostic tools to ultimately ensure better patient care. To witness these advanced technologies and much more, visit the Roche Diagnostics Middle East stand at Sheikh Maktoum Hall, Stand MC 10. MICROBIOLOGY SPECIALIST LAB M TO SHOWCASE QUALITY, CONVENIENT CULTURE MEDIA AT ARAB HEALTH 2015 M icrobiology specialist Lab M will showcase its new convenient culture media product ranges at Arab Health. With a commitment to providing high quality products that aid laboratories in their efforts to optimise efficiency and workflow, Lab M has long been recognised for its comprehensive portfolio of dehydrated culture media (DCM). Now a number of these formulations are available as Pinnacle™ pre-poured plates and µPREP™ ready-to-reconstitute bags for ease of use in any laboratory. Lab M’s µPREP™ ‘just-add-water’ range of culture media includes µPREP Half Fraser Broth ISO (+FAC) for the isolation of Listeria spp and µPREP Buffered Peptone Water (BPW) ISO used extensively as a pre-enrichment medium in Salmonella testing. These complete media are provided sealed in a 20-litre bag. Simply adding water through the filter means there is no mess and no need to autoclave. For ultimate convenience, Lab M now also provides its microbiological culture media as Pinnacle™ pre-poured plates. Users benefit from plates, prepared by the manufacturer under a stringent quality management system in a GMP environment. Managing Director of Lab M, Ian Morris said, Image © Lab M “We are very much looking forward to our second attendance at Arab Health and building on the successes of 2014. The last couple of years have been important ones for Lab M having significantly Booth no. S3D70 Sheikh Saeed Hall 3 10 facebook.com/arabhealth grown our manufacturing facilities, head count and R&D capacity. This has enabled us to commence large-scale manufacture of pre-poured plates and to launch a number of new products.” LEARN MORE Lab M specialists will be available throughout Arab Health 2015 in Sheikh Rashid Hall, stand RH33 to discuss individual requirements. MONDAY 26 January 2015 “Everything we do, we do with passion – and we do it for life.” Stefan Dräger, Chairman of the Executive Board 2015 h t l a e H 3D30 S b a h r t o A o e 3, B t th a all Visit us SHK. Saeed H cated: 5418 Lo www.draeger.com/arabhealth #arabhealth @arab_health 11 ARAB HEALTH daily dose A JOURNEY OF 40 YEARS By: Dr Zeyad Al Moosa, Managing Director, GulfDrug G ulfDrug is proud to have such a long association with Arab Health and would like to congratulate everybody involved with the event on its 40th anniversary. Over the last four decades, Arab Health has become one of the world’s largest medical technology exhibitions and conferences. It has catapulted UAE’s healthcare industry into the focus of the entire world, and has brought the world’s greatest medical technologies and innovations together in one, big forum. Our first participation in Arab Health dates back to 1979. At that time it used to be a biyearly congress until it changed to a yearly event in 2001. Since then, GulfDrug has benefitted greatly from this event. Not only did it create a sense of trust and commitment between all parties to invest in the Middle East markets, but also allowed the UAE to blossom into a regional centre for manufacturers and providers to set up their regional and international offices, as well as support and training centres. We have witnessed first-hand how Arab Health has evolved from an exhibition where all exhibitors could fit in two halls in the 90’s, to what we see as a mega event today. It’s a clear reflection of what a long journey we have covered and how glorious our future is going to be. All this history has contributed to what Dr Zeyad Al Moosa GulfDrug is today: A professional, knowledgeable organisation, with provision of integrated healthcare products and services, and capability to completely fit out hospitals and clinics of all sizes and complexities. We at GulfDrug foresee that the growth expectations for distributors and manufacturers for the next five years will consistently be in the double digits, due to the increase in population, healthcare awareness, population ageing, mandatory insurance coverage of the population, an increase in healthcare tourism, and increased investment in infrastructure in both the governmental and private sectors. We have already started implementing major plans in increasing our investments in infrastructure, facilities and people. Having moved to our new head office in Al Barsha, Dubai in November 2014, we have increased our ability to absorb the increase in technical and operational staff. In 2015 we are increasing our logistics and warehousing capacity to better handle the increasing volume of business. We look forward to the years to come and are happy to be associated with Arab Health, which has and always will be a great exhibition and conference that keeps building bigger and more solid bridges between cultures, technologies and people across the world. Images © GulfDrug AN EVER-GROWING FRENCH PRESENCE AT ARAB HEALTH AND MEDLAB 2015 There will be 118 French companies exhibiting their products at the Pavilion organised by UBIFRANCE, the French Agency for International Business Development. Occupying about 1,350m2 of exhibition space in the Za’abeel and Sheikh Rashid HallS, the companies will be enjoying a much larger area to showcase their know-how. F rance’s medical products and services industry accounts for a market wor th about €20bn, or 10% of the world market. Driven by 1,079 high-added-value companies in the field of medical technologies, it is a cutting-edge industry enjoying constant growth, employing 65,000 people. 94% of those businesses have less than 250 employees. The manufacturing techniques, which are highly precise for a wide range of products, must meet ethical and regulatory requirements in terms of safety and quality. A large par t of production operations (assembly, filing and polishing) are done by hand; automated assembly is not always possible, and some of the controls require a human presence. As a major event, Arab Health and Medlab 12 facebook.com/arabhealth 2015 attracts an increasing number of manufacturers every year, hailing from all regions in France and presenting highly innovative products; 38% of them will be attending for the first time. Found in both exhibitions, they will display their latest products in or thopaedics, diagnostics, healthcentre consumables and facilities, air treatment, waste processing, hospital supplies and home care. With help from regional par tners like CENTRECO and Lille Eurasanté, who will be exhibiting at the French Pavilion with nine and seven businesses respectively, the very latest in French innovations will be clearly on display. Their advanced technical skills are sure to meet the requirements of a very demanding local market which is currently experiencing a boom in those fields. Together with UBIFRANCE, Orange Business Services is sponsoring the French Pavilion. The Orange Group’s B2B division will be introducing its own health-related solutions. For the past 10 years, the Group’s entity Orange Healthcare has provided its exper tise in means of communication to serve healthcare professionals. As the first telecom operator to be cer tified as a ‘hosting company for private health data’ by France’s Health Ministry, Orange has played a par t in modernising infrastructures and healthcare systems, as well as supplying health centres with communication solutions. Orange guarantees reduced costs, optimal quality and improved access to health, for instance by providing solutions to manage chronic illness. MONDAY 26 January 2015 The TrueBeam® system – Radically different TrueBeam created a revolution in Radiotherapy; it was the first system that combined ultra-high dose rates with sub-millimeter accuracy for ultrafast and safe treatment delivery. Precise It’s a versatile, innovative treatment platform for high-precision Efficient The TrueBeam system enables a truly integrated approach image-guided radiotherapy and radiosurgery. to treating cancer with image-guided radiotherapy, allowing Versatile clinicians to treat tumors located in close proximity to critical structures. More options for difficult cases mean more options for your patients. ® for SRS. Simply RapidArc Revolutionary. Proven as a Technology. Possibilities as a Result. Varian Medical Systems International AG Cham, Switzerland Phone +41 -41 - 749 88 44 www.varian.com [email protected] #arabhealth @arab_health 13 ARAB HEALTH daily dose CERNER MIDDLE EAST TO HIGHLIGHT IT SOLUTIONS AT ARAB HEALTH 2015 2015 HIGHLIGHTS EVENT MOBILE APP View the exhibitor listing, product listing, interactive floor plans, and all the show information you could need – all from your own device! Download now: www.arabhealthonline.com/mobileapp WIN FANTASTIC PRIZES • Win a BMW 4 Series Gran Coupe: Visit stand Z4B60 in Za’abeel Hall 4. • Win a Dream Holiday worth AED 15,000 – DAILY! Enter each day at stand Z4AA60 in Za’abeel Hall 4. • Win a Samsung Galaxy Tab 3: Take a selfie at the exhibition and upload it to social media with #arabhealth DEALERS & DISTRIBUTORS LOUNGE Visit stand Z4N60 in Za’abeel Hall 4 to benefit from a free networking lounge and free coffee exclusively for Dealers & Distributors. Also visit the Dealers & Distributors Wall to Cerner to showcase healthcare IT solutions across the continuum of care C erner Middle East has joined thousands of local, regional and global healthcare companies at Arab Health 2015 to demonstrate its broad range of healthcare solutions and services. During the event, Cerner will highlight IT solutions for the flourishing region’s healthcare sector, including: A comprehensive behavioural health medical record, including nursing workflows, specialised patient summary pages, group and individual therapy documentation, multi-disciplinary care plans, electronic patient safety rounding, physician speciality workflows and interdisciplinary patient discharge workflows A fully integrated Women’s Health maternity record to capture data spanning from the patient’s first antenatal visit through delivery and the neonatal record.The solution integrates unique elements of the perinatal workflow with the patient’s medical record A HealtheLifeSM-enabled Population Health patient portal to provide patients access to clinical notes, upcoming appointments and other information through a secure website. The patient portal encourages individuals to become active participants in their care by closely collaborating with their care team. “The emergence of universal healthcare in the UAE is an opportunity to demonstrate how Cerner’s technology-enabled solutions can drive improvements and reduce costs for clinical settings throughout the Middle East”, said Michael Pomerance, Vice President and Managing Director, Cerner Middle East and Africa. “Arab Health is an ideal platform to discuss with industry leaders and decision-makers ways to enhance the delivery of healthcare services in the region.” post your business requirements and contact details so exhibitors can get in touch with you directly during the exhibition. FUTURE OF SURGERY ZONE The Future of Surgery Zone at Arab Health is an interactive hub providing an opportunity for healthcare professionals to learn about and experience innovative surgical methods and technologies. The Future of Surgery Zone is located at the Plaza Hall. THE APPRENTICE Launched by Aster DM Healthcare in association with the Arab Health Congress & Exhibition, this programme provides a platform for young healthcare professionals to showcase their skills, improve their knowledge, and potentially become a permanent part of Aster DM Healthcare. Visit stand Z4N30 in Za’abeel Hall 4. www.arabhealthonline.com 14 facebook.com/arabhealth Michael Pomerance MONDAY 26 January 2015 #arabhealth @arab_health 15 ARAB HEALTH daily dose 18 facebook.com/arabhealth MONDAY 26 January 2015 CARESTREAM HEALTH IS THE FIRST COMPANY TO RECEIVE US NAVY CERTIFICATION TO IMPLEMENT MEDICAL IMAGE MANAGEMENT SYSTEMS T he certified CARESTREAM Vue PACS, which has passed strict DIACAP security tests, is showcased on the Carestream stand during Arab Health. As a result of meeting some of the most stringent product security requirements for the US Navy’s DIACAP certification process, Carestream is now the first company approved to provide the latest Picture Archiving and Communications Systems (PACS) for use in US Navy medical facilities. Carestream has received an official ATO (Authorization to Operate) from the Department of Defense (DoD) Information Assurance Certification and Accreditation Process (DIACAP), enabling the Navy to implement Carestream’s Vue PACS at any Naval medical treatment facility across the globe. DIACAP is a process by which information systems are tested and certified for compliance with DoD security requirements and accredited for operation. While security testing of new systems typically occurs in a lab environment, Carestream’s PACS, along with its cardiology PACS feature, was successfully tested in an extremely complex environment at one of the largest DoD hospitals that performs more than 300,000 radiology exams a year. Carestream’s native reporting application—a voice recognition and reporting feature that allows remote reading by radiologists, which expedites the delivery of radiology reports and helped eliminate transcription costs—was also included in the Navy’s field testing process. With the diagnostic viewing capabilities of Carestream’s Vue PACS, users can consolidate the reading of all medical imaging exams onto a single platform, which can boost productivity while simplifying operations and support. Its scalable, web-enabled platform integrates smoothly with complex environments and complies with XDS, HL7, DICOM and IHE standards. Carestream Vue PACS offers radiology reading tools such as MPR, MIP, MinIP, volume rendering, tissue definition, vessel tracking, and cardiac analysis. The PACS can automatically register 3D imaging data sets (such as MR and CT) to help highlight subtle changes in anatomy and improve clinical collaboration. Vue PACS also provides lesion management as a native clinical tool that can simplify the comparison process between different data sets and supports oncology follow-up with bookmarking and tracking of general anatomy over time. As part of Carestream’s ‘Knowing Matters’ customer strategy, Carestream’s Vue portfolio of healthcare IT solutions is designed to offer greater value and insight for clinicians, foster collaboration, control costs, and streamline dataflow. The company’s Vue solutions amplify the clinical, business and IT value of radiology services. Carestream’s x-ray products and healthcare IT systems are used by the US government’s veterans integrated service networks, the US Army and US Air Force, as well as by many foreign governments around the world. The company regularly receives high marks for the performance of its Vue PACS for use in radiology, cardiology and mammography, with some of the most well-known hospitals and national healthcare systems implementing Carestream’s PACS. Carestream’s Vue PACS. Image © Carestream demo For a visit nstratio u S3D70 s at stann, d in Sh Saeed eikh Hall 3 She Savors Every Moment With Her Grandchild Thanks To Early Detection Advanced Medical Imaging at American Hospital Dubai The hospital’s advanced medical imaging technology including a range of digital body scanners that detects serious disease quickly. From cancer to neurological conditions, these scanners present detailed images in real time, enabling fast diagnosis with a high degree of patient comfort. Tests are designed to show even the smallest changes in your body, from cancer development to treatment response and any recurrence. This new technology makes it possible to diagnose and treat disease earlier, allowing patients to live a better and healthier life. Tel +971 4 377 6015/6669 ZZ54666 Email [email protected] Website ahdubai.com #arabhealth @arab_health 19 ARAB HEALTH daily dose INSIGHT CLINICAL LOGISTICS: IMPROVING WORKFLOW AND PATIENT THROUGHPUT IN THE OR, A&E, ICU AND PATIENT WARD W orkflow management is one of the greatest operational challenges facing hospitals today. Patients wait in the A&E while someone calls to see if a bed is available on the patient ward. OR costs skyrocket due to downtime from cancelled procedures. Hospitals have been lacking the insight into workflow and patient throughput that delivers measurable economic benefits. MAQUET recognises the value of a comprehensive, easy-to-use clinical logistics system that gives clinical staff the information that they need to improve patient care. INSIGHT Clinical Logistics features four components, each specifically geared to the clinical area that it ser ves; emergency, surgical, ICU and patient ward. The Danish Welfare Technology Foundation funded an independent study of the emergency component. It showed an increase in productivity as patient throughput was increased by 19% after INSIGHT was implemented at the regional hospital of Horsens, Denmark. The system tracks patients from admission to discharge, often star ting in the accident and emergency depar tment. “INSIGHT Emergency has had an incredible effect on our over view”, says Ove Gaardboe, Chief Physician. “We are saving time and improving the quality of our treatment.” INSIGHT Clinical Logistics is designed to improve interdepar tmental communication. Because the OR status is being tracked at all times, all surgical suite staff know the status of each procedure. Cleaning crews can be queued and ready for an efficient turnaround, while patients are prepped and ready. “INSIGHT Surgical has improved our working environment drastically”, says MarieLouise Ulsøe, Head Nurse. “The work has become less stressful and we have increased the number of operated patients per day.” An assessment of the surgical component has demonstrated positive outcomes with a 15% higher utilisation of operating rooms and a 66% reduction in the number of cancelled procedures. Large touchscreens present each area of the hospital with exactly the information that they need. There is no hunting for critical data and unnecessar y information to waste time sifting through. “We have a significantly better over view over the treatments and flow of our patients as well as our staff ”, explains Ulsøe. INSIGHT Clinical Logistics is designed to be easy for ever yone to use, with a minimal learning cur ve. “It was surprisingly easy for the staff to implement the solution and learn how to use it”, explains Claus Brøckner, Chief Surgeon. “Ever yone, even those who normally are sceptical about star ting to use new IT solutions, has been happy with the new system because it’s so intuitive.” INSIGHT The Clinical Logistics Solution • Efficient workflows throughout the hospital • Easy access to all relevant information • Improved interdepartmental communication • Four components: Emergency, Surgical, ICU and PatientWard Maquet | The Gold Standard Visit us in Sheikh Saeed Hall 2, booth no. S2G30 and see how INSIGHT can streamline clinical workflows 20 facebook.com/arabhealth MONDAY 26 January 2015 #arabhealth @arab_health 21 ARAB HEALTH daily dose KARL STORZ - ENDOSKOPE: QUALITY AND INNOVATION - THE BASIS OF INTELLIGENT SYSTEM SOLUTIONS F or almost 70 years, KARL STORZ have been globally known to physicians as a manufacturer that provides the various medical specialities with a full range of high quality products. KARL STORZ’ customers receive all their requirements from a single source with products that range from endoscopic instruments to hightech documentation solutions, fully integrated operating rooms, and software-supported workflow solutions. At this year’s Arab Health, KARL STORZ will showcase intelligent novelties in endoscopic imaging and data management, as well as the innovative solutions for clinical communication and optimization of workflows. flexible integration of the new technology into the existing camera platform IMAGE1 SPIES™. KARL STORZ ICG For imaging beyond the white light mode, KARL STORZ offers the ICG fluorescence-supported NIR (near infrared) system, a cost-effective option for perfusion assessment, lymph node detection, and bile duct visualisation during surgical procedures. AIDA ® & AIDA ADVANCED REPORTER Within the same context, we will be unveiling the newest generation of the KARL STORZ AIDA® IMAGE1 SPIES™ KARL STORZ technical solutions for targeted enhancement of endoscopic imaging information allow physicians more precise assessment of the surgical site. The IMAGE1 SPIES™ FULL HD platform offers the endoscopic standard image with three additional visualisation technologies: Contrast enhancement, homogeneous image illumination, and spectral hue shifts. Tissue will thus be visualised in a more differentiated manner specific to the individual diagnosis and surgical situation. 3D CAMERA GENERATION The latest 3D camera generation, which is a new and essential component of the company’s system approach, has now expanded the modular endoscopic camera platform IMAGE1 SPIES™ by incorporating a 3D module in FULL HD quality, with obvious advantages to the user, such as but not limited to, a more brilliant image quality in 3D and 22 facebook.com/arabhealth documentation unit, which now has the option of recording and displaying 3D image information. Following data generation, structured data storage and utilisation has to be ensured; KARL STORZ addresses this demand with the latest version of the AIDA Advanced Reporter (AAR). The AAR is a solution that supports physicians who wish to generate reports in both a structured and individualised manner. VISITOR1® With the innovative communication system VISITOR1®, KARL STORZ offers an intra-operative telementoring robot, which allows virtual integration Image © KARL STORZ of external experts during surgical procedures and provides solutions for clinical communication and workflow/resource control. OR1™ With more than 3,000 installed OR1™ systems, KARL STORZ is the leader in the field of integrated operating rooms. The OR1™ allows centralised and ergonomic control of endoscopic devices via touchscreen or speech control from within the sterile area and simultaneously offers an archiving system with numerous functionalities. Furthermore, the OR1™ facilitates worldwide telemedical communication from the OR via audio and video transmissions. The new generation KARL STORZ OR1 FUSION™ is based on IP network technology and enables the digital transmission of video and audio data with virtually no delay and no compression. Additional sources can be integrated through the dynamic Plug & Play solution to ensure flexibility. Furthermore, the new generation only requires universal network cables, which further facilitates integration of the devices. With the IP network technology, KARL STORZ OR1 FUSION™ is perfectly ready for future developments in medical technology. With these exhibition highlights, KARL STORZ once again reinforces its reputation as an innovative leader, that impressively substantiates the ranking of the German business weekly WirtschaftsWoche, which in April 2014 named KARL STORZ as the ‘most innovative German medium-sized company’. With more than 50 domestic and global subsidiaries, KARL STORZ once again presents itself as a globally active family company that consistently invests in research and development and in customer service and support. MONDAY 26 January 2015 SOMATOM DEFINITION EDGE BRINGS DUAL ENERGY TO ROUTINE CT IMAGING Article provided by Siemens Healthcare W ith the new version of the SOMATOM Definition Edge, Siemens Healthcare has created the basis for establishing the dual energy procedure in clinical routine. The innovative x-ray tube concept in the new CT scanner, enables simultaneous imaging at two different energy levels for the first time in single source computed tomography. Thanks to a novel user- and patientfriendly measurement method, information on tissue and other material can be obtained as well as traditional morphological data, even during examinations with high contrast media dynamics. This means that more patients will benefit from the added value of dual energy imaging. detector side after penetrating the patient. With kV-switching, the segmentation of the measuring points significantly impairs the image quality due to the limited data per energy level. At the same time, increased x-ray doses are inevitable because the dose cannot be modulated to reduce radiation. NEW SOURCE DESIGN SPLITS THE X-RAY BEAM INTO TWO ENERGY SPECTRUMS Not so with the TwinBeam Dual Energy technology from healthcare, in which the x-ray beam emitted is split into two different energy spectra before reaching the patient thanks to an innovative tube design. This means that the SOMATOM Definition Edge generates the dual energy images at the same time. The benefits of the new procedure are illustrated by the diagnostics in a case of suspected pulmonary embolism: Due to the improved tissue differentiation and the precise representation of contrast media distribution, vascular occlusions can be quickly identified and their size determined. In addition to increasing the diagnostic strength of clinical images, TwinBeam technology also minimises the x-ray dose required in a different way to other single source dual energy procedures. All dose-reducing Siemens technologies can be used with the SOMATOM Definition Edge. This now SINGLE SOURCE DUAL ENERGY – HOW IT WORKS In dual energy imaging, the same region of the body is examined using two different energy levels. The two datasets offer more detailed information about tissue composition that goes beyond pure morphology. For instance, metal artifacts caused by implants such as artificial hips are reduced considerably, while tissue and bone structures can be displayed more clearly. However, in cases where data have been acquired using fast kV-switching or dual layer detector technology – dual energy imaging involved significant drawbacks. Single source dual energy images acquired with these methods were excluded for many important radiological use cases, because the tube does not emit the two energy spectra at the same time, only in succession through rapid switching or through spectra separation at the With the new version of the SOMATOM Definition Edge, Siemens Healthcare has created the basis for establishing the dual energy procedure in clinical routine. The innovative x-ray tube concept in the new CT scanner enables simultaneous imaging at two different energy levels for the first time in single source computed tomography. Image © Siemens Healthcare also includes ADMIRE, the model-based iterative reconstruction procedure that was just recent released on the SOMATOM Force and whose scanner-specific algorithms can reduce x-ray doses further still, achieving excellent image resolution and extremely low image noise even at low doses. ITERATIVE METAL ARTIFACT REDUCTION FOR CLEARER MATERIAL DIFFERENTIATION To further improve not only the quality of dual energy examinations, but also of conventional CT scans, Siemens Healthcare is additionally introducing a new iterative algorithm for metal artifact reduction with the new SOMATOM Definition Edge: iMAR.This allows respective artifacts – caused by implants, artificial joints or pacemakers – to be reduced significantly. Such artifacts may lead in the worst case to non-diagnostic images by concealing the relevant pathologies. Even if a radiologist wishes to check whether bone fractures have healed and metal objects such as screws and plates can be removed, the iMAR algorithm can be used to clearly assess the anatomical details in the area of transition between bone and metal. With the aid of iMAR, streak artifacts can, for instance, be significantly reduced in clinical images, according to first scientific results. The products/features (here mentioned) are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Further details are available from the local Siemens organisations. A91MR-9385-A1-7600 Visit us at booth S1D10, Sheikh Saeed Hall 1 MAGNETOM Amira Improve patient outcomes while reducing annual operating costs by up to 20.000€1 www.siemens.com/amira Providers and stakeholders around the world are working to increase the efficiency of healthcare systems. The aim: to achieve better outcomes for patients. With MAGNETOM Amira you can: MAGNETOM Amira2 is specifically designed to enhance clinical capabilities and deliver comprehensive, advanced MRI technology. It helps extend care to a greater number of patients, improve the patient experience and boost process efficiency – at lower costs per scan. • Gain diagnostic value with FREEZEit • Increase patient comfort with Quiet Suite 1 2 • Streamline operations with 10-min exams • Save 30% energy3 with Eco-Power 3 Comparison with older MRI generations. Data on file. MAGNETOM Amira is currently under development; is not for sale in the U.S. and other countries. Its future availability cannot be guaranteed. During standby mode. Data on file; results may vary. Answers for life. 2661_MR_Ad_Magnetom_Amira_en_267x180_K1.indd 1 #arabhealth @arab_health 16.12.14 08:17 23 ARAB HEALTH daily dose CREATING A HEALTHIER FUTURE Philips is introducing a fresh perspective on the future of health at Arab Health 2015 R oyal Philips is a diversified technology company, focused on improving people’s lives through meaningful innovation. Philips looks beyond technology to the experience of patients, providers and caregivers across the patient journey. This year at Arab Health, Philips is showcasing some of its latest innovations spanning across healthy living, prevention, diagnosis, treatment, recovery and home care, telling a rich story that demonstrates meaningful innovations across the health continuum. Philips is committed to delivering solutions for the most meaningful moments of care, whether in the hospital or at home. Dedicated to helping people maintain their health outside the doctor’s office, Philips helps clinicians make better informed decisions for their patients, bringing together clinical breadth and depth of expertise, technology and services, actionable data, consultative new business models and partnerships. Improving experiences of patients, providers and caregivers means moving outside the hospital walls. In today’s healthcare environment, it’s not enough to just diagnose and treat. Patients and clinicians alike are looking for ways to manage health conditions before issues arise, and to stay healthy long after treatment. Philips solutions are strategically developed to work cohesively across the patient journey. ACROSS THE CONTINUUM The key focus at Arab Health revolves around the latest innovations across prevention, diagnosis, treatment and recovery. Philips provides digital solutions to measure and monitor the patient’s condition, and empower patients to take control of their own health, such as the HealthSuite Digital Platform that seamlessly integrates data to transform the delivery of patient care and provide better access to data from hospital to home. To drive definitive diagnosis, Philips offers solutions that are designed for ‘First Time Right’ imaging, helping providers manage workflow efficiency. Some of the key innovations showcased at Arab Health for the first time include the Ingenia 1.5T S complemented with the patient in-bore solution to create an immersive experience, allowing the patient to relax through the exam, the Affiniti, ultrasound system, providing innovative technology to help radiology/ultrasound departments facing more patients with fewer resources deliver high quality patient care, and IntelliSpace Portal 7.0, combining high quality images, advanced analysis, and workflow efficiency tool into a single advanced analysis solution. In the area of treatment, the Veradius Unity makes its debut at Arab Health. Designed to improve the workflow and throughput by establishing exceptional communication between the physician, operator and C-arm, the Veradius Unity is an example of how Philips creates new clinical procedures for safe and effective adaptive therapies. Philips’ breadth of diagnostic and treatment solutions offer real-time tools to connect patient information with clinician knowledge, resulting in more personalised care, while innovations for recovery and wellness provide a safer transition from hospital to home. improve the lives of 3 billion people by 2025. Ageing societies and the rise of chronic diseases means healthcare costs are spiralling out of control. People are beginning to value their health and wellbeing more, as technology becomes more pervasive, integrated and intelligent and at home, it changes how people behave. To make healthcare more effective there is a need for more integration and personalisation. Patients will benefit from faster and better diagnosis, efficient personalised treatment and better aftercare. In short: healthcare that is more accessible, with better outcomes at lower costs. Philips is uniquely positioned to help reshape and optimise population health management by leveraging big data and delivering care across the health continuum, from healthy living and prevention to diagnosis, minimally invasive treatment, recovery and home care. Philips believes that opportunity lies in an increasingly connected world, where societies are looking for more effective and lower cost health solutions, meaningful innovations built around people. MORE INFO See it yourself during Arab Health at Philips stand S2C10, or visit www.philips.com/healthcare SHAPING THE FUTURE Following its rebranding and new positioning ‘innovation and you’, Philips has continued to demonstrate its commitment to addressing the needs of the people and of the world as a whole, to Workflow Image © Philips meets wow Choosing a new ultrasound system is all about balance. You want the latest technology that needs to be out of the box usable. You need accurate diagnostic information quickly, a simplified yet intuitive user interface, and easy access to the critical features to produce the results you need. All in an ergonomic design, to let you work with less reach and fewer steps. You want the new Philips Affiniti. Visit us at booth # S2C10 The new Philips Affiniti ultrasound system. It understands your everyday. www.philips.com/affiniti Philips_Affiniti_PrintAD_267x180_v1.indd 1 24 facebook.com/arabhealth 09/12/14 13:45 MONDAY 26 January 2015 BOSTON CHILDREN’S HOSPITAL PATIENTS’ STORIES: YOUSEF’S VEIN OF GALEN SURGERY W TRAINS FOR OXYGEN Shanghai in China is home to the world’s largest network of metro stations in the world. The trains made 2.5 billion trips last year alone, covering 334 total miles of track and serving more than 8 million people every day. It’s impressive, but nothing compared to the volume, distance and speed of blood moving through the human body. The average adult body has 5.5 litres of blood, which circulates through the entire body three times every minute. Laid end to end, the total length of all the body’s arteries, capillaries and veins can reach up to 96,000km, enough to wrap around the earth twice. Like metros, the vascular system is made up of different parts, each playing a specific role in transporting oxygen throughout the body. Arteries carry high-pressure, fast-moving oxygenated blood from the heart to the rest of the body. They feed into capillaries, which slow the flow of blood enough for surrounding tissue to absorb oxygen, decreasing the blood’s pressure at the same time. When it has no more oxygen to deliver, blood (by then lowpressure and slow moving) moves into the venous system, which carries it back to the lungs and heart to be re-oxygenated. Like any metro system, the vascular system can fall victim to crippling congestion. Heavy traffic in areas only capable of supporting low traffic can cause delays and breakdowns. That’s what happens when the body develops an Arteriovenous Yousef Alrkhayes and his father. Image provided by Boston Children’s Hospital hen Yousef Alrkhayes was diagnosed with a rare, life-threatening Vein of Galen Malformation (VOGM) at just a few days old, his parents wanted the world’s best care for their son. That meant travelling from Kuwait to Boston Children’s Hospital with Yousef. Malformation (AVM). The body never develops capillaries in specific areas, leaving high-pressure, fast-moving blood to flow directly into the veins. Without the capillaries, the blood doesn’t slow down enough to deposit oxygen to the surrounding tissue, which then signals to the heart that it needs more oxygen. The heart starts pumping harder and harder and harder, creating a vicious cycle. “The hearts of children with AVMs are beating very rapidly, all the time,” Darren Orbach, MD, PhD, interventional radiologist at Boston Children’s Hospital explains. “It’s not even just the speed, but also the contractility; the heart increases its oomph with each squeeze.” This supply and demand problem was the very cause of Yousef ’s heart strain, but at the time, back in Kuwait, no one knew the problem was rooted in his brain. Darren Orbach, MD, PhD, interventional radiologist at Boston Children’s, treats as many as 15 VOGM patients every year. That track record went far in reducingYousef’s family’s fears. Most surgeries to correct VOGMs involve inserting a catheter into a major artery, usually entering mid-thigh, and then snaking it around the heart and neck to reach the brain.The surgeon inflates a small balloon attached to the outside of the catheter to close off the connection between the arteries and veins and then injects a glue to seal off the connection. Once the glue has set, the balloon is deflated and the surgeon removes the catheter.Yousef’s surgery stretched out to seven hours. However, Dr Orbach successfully treated the malformation, puttingYousef on the path to an active and full life. To read more about Yousef and Boston Children’s #1 ranking in Neurology and Neurosurgery by U.S News & World Report, visit www.bostonchildrens.org/yousef. Modular Interior Construction... Is it a better Approach for healthcare? One of the things we trying to change is our behaviors as it relates to how we build out our interior environments in Healthcare applications. The amount of change that occurs with-in hospitals is constant: most hospitals have a permanent construction trailer on site to be able to handle the reality of their environments not being able to keep up with the need for flexibility. “There is a better way to design and build our interiors”, one that gets away from fixed in place construction. None of us has a crystal ball; we don’t know what technology is going to look like 2 years, 4 years, or 10 years from now. Yet we are trying to design spaces conventionally that are in need to be flexible enough to handle whatever may be coming our way. Construction behaviors in healthcare environments need to change, focusing on reduce and reuse, saving costs through rapid interior construction and enhanced coordination, creating environments that help the overall healing process of patients and retention of staff. This is true sustainability - and this is what NMG modular interior solutions are all about. Image © NMG solutions NMG (Inspired Design-Build Solutions). We look forward to welcome you at Arab Health 2015, Hall 4 Booth 4B50 #arabhealth @arab_health 25 ARAB HEALTH daily dose Cielo Healthcare is the leading provider of Recruitment Process Outsourcing (RPO), Strategic Recruitment Projects and Physician Hiring Solutions to Healthcare organisations across The Middle East and North Africa (MENA). Our teams based in Dubai, Qatar, KSA and other key MENA locations interface with Cielo Healthcare’s world-wide network of offices to find, attract, engage and hire critical local and global talent for our dedicated Healthcare clients. Moorland Gray, previously Carmichael Fisher Middle East, is the largest and most successful executive search firm in the MEA region having delivered more than 1,000 searches in the past eight years. Moorland Gray has improved performance for hundreds of healthcare clients across the region and are the first port of call for Chairmen and Chief Executives looking to strengthen their leadership teams. moorlandgray.com | +971 (0) 4 279 6300 Eradicate recruitment agency usage, access the very best global Healthcare professionals and save your organisation money with an in-house Recruitment Solution from Cielo Healthcare MENA. www.cielotalent/HC | +971 (0) 4 279 6302 Recruitment Process Outsourcing | Physician Recruitment | Consulting OLYMPUS EXPANDS ITS THUNDERBEAT PRODUCT LINE T he THUNDERBEAT Open Extended Jaw was launched to the Middle East markets in December 2014 and will be showcased at Arab Health for the first time. It is the first Olympus product to be specially designed for use in open surgical procedures. THUNDERBEAT Open Extended Jaw is based on the established THUNDERBEAT concept of synergistic energies. With one crucial difference: The instrument has been further optimised to suit the requirements of open surgery. Compared to the laparoscopy model, it is shorter overall, but its jaws are 25% longer to enable comfortable use. THUNDERBEAT Open Extended Jaw cuts quickly, reliably seals blood vessels, and enables very precise tissue dissection, without any unwanted bleeding. The ergonomics of the handle have also been adjusted to facilitate accurate operations. “THUNDERBEAT Open Extended Jaw is one of the most versatile instruments currently on the market”, says Frank Drewalowski, Managing Director, Medical Systems Division, Olympus Europa SE & CO. KG. “Our aim was to offer surgeons the THUNDERBEAT precision and convenience they are already familiar with in laparoscopies for open procedures.” In addition to general surgery, the THUNDERBEAT Open Extended Jaw is particularly THUNDERBEAT Open Extended Jaw; Energy Devices Olympus Europa. Image © Olympus Europa SE & Co. KG suitable for gynaecological and urological procedures. As with the THUNDERBEAT model for laparoscopies, the THUNDERBEAT Open Extended Jaw can also be used in the integrated Olympus ENDOALPHA operating room. SAFETY FOR PATIENTS AND SURGEONS The laparoscopic THUNDERBEAT was launched on the market in 2012. In its development, Olympus was focused on a very clear goal: The instrument needed to be as versatile as possible in order to reduce the number of instrument changes, decrease operation time, and limit blood loss, thereby enabling procedures to be performed in a more precise and gentle manner. This also meant added safety for patients and surgeons. THUNDERBEAT is the world’s first instrument to combine a bipolar high-frequency current with ultrasound technology to create a synergistic form of energy, which reliably cuts and seals tissue and vessels in one step, thereby enabling fast, precise and safe surgical procedures. THUNDERBEAT is currently the fastest cutting instrument of its kind. It allows surgeons to reliably seal blood vessels up to and including 7mm in diameter, with minimal thermal spread. The instrument is extremely versatile, as it provides surgeons with a dissector, cutting instrument (ultrasound) and sealing instrument (bipolar) in one product. The THUNDERBEAT system consists of two generators. In addition to its ultrasound generator, it also features a complete, integrated high-frequency (HF) generator compatible with most conventional HF instruments found in operating theatres, rendering the use of different HF systems superfluous. THUNDERBEAT OPEN EXTENDED JAW: PRODUCT FEATURES AT A GLANCE he ee t To s d NDERBEAT nde THU Exte the n isit nd e p O w, v ta Ja pus s ing m Oly 30 duralth 3E b He Ara 2015 26 facebook.com/arabhealth With an elongated tip, fine design and jaw opening force, it allows surgeons to perform the most intricate tissue dissection tasks THUNDERBEAT can reliably seal even large vessels with diameters of up to and including 7mm, meaning they do not need to be clamped or ligated Secondary bleeding can be immediately stopped by the bipolar mode With its atraumatic teeth and uniform tissue compression, the jaw design allows the tissue to be gripped and held safely The ergonomic handle and its optimised angle adjustment reduce surgeon’s hand fatigue. MONDAY 26 January 2015 EVIS LUCERA ELITE Advancing the art of Endoscopy In the pursuit of the perfect endoscopy system, Olympus introduces EVIS LUCERA ELITE as the next milestone towards improved clinical outcomes Visit us on stand 3E30 at Arab Health 2015. Follow us on Twitter @OlympusMedUIMEA www.olympus.co.uk/medical #arabhealth @arab_health 27 ARAB HEALTH daily dose ARE YOU OUR NEXT APPRENTICE? Q Article provided by Aster DM Healthcare Dr Azad Moopen uality professionals are the need of the hour for the healthcare sector in UAE and India. Aster DM Healthcare has been a trusted name for nearly three decades with 239 establishments of compassionate care across eight countries, served by more than 10,000 employees, 1,100 doctors, offering more than 4,000 hospital beds. The Aster DM Apprentice programme is presented in association with the 40th edition of Arab Health Congress & Exhibition. The four-day long programme, the first of its kind in the GCC, intends to provide a platform to young healthcare professionals to showcase their skill sets, upgrade their knowledge and be a part of the healthcare group. Commenting on the launch of Aster DM Apprentice at Arab Health, Dr Azad Moopen, Chairman and Managing Director of Aster DM Healthcare, said, “We are excited to be one of the key associates of Arab Health Congress, the region’s most important scientific medical demonstration.This is part of our commitment to support innovation and development of the region’s healthcare industry. We will host Aster DM Apprentice in the next three years consecutively, continuing through the 2016- and 2017 editions of the Arab Health Congress.” The programme is open for candidates with MBA/MHA (Masters in Healthcare Administration) and 2-3 years clinical or healthcare experience, or any postgraduate with 5-6 years of hospital/ clinical experience. Aspirants should submit their CVs to [email protected] Aster DM’s healthcare panel will look over the CVs and shortlist candidates and finalists by assigning a specific set of subject-related tasks. “The Aster DM Apprentice programme will present competency-based models to healthcare professionals participating in the Arab Health Congress, in response to the need of the region’s healthcare sector for highly skilled healthcare workforce”, Dr Moopen explains. Participating in the event will open up avenues for acquiring, updating and fine-tuning knowledge and skill sets in the healthcare sector. The winning candidate will be with working with us for at least a year. The candidates selected as apprentices will work along with the C Suite of Aster DM Healthcare including the Chairman for six months with successful apprentices absorbed as full-time staff. UNIVERSITY HOSPITAL DEBUTS AT ARAB HEALTH 2015 BMW 4 Series Gran Coupé Sponsored by Drop your Coupon at Stand Z4B60 Win a Holiday worth AED 15,000 Daily! Drop your Coupon at Stand Z4AA60 U niversity Hospital Sharjah (UHS) is participating in the prestigious Arab Health Exhibition & Congress for the first time in 2015. Speaking about the event, Mr Michael Stroud, CEO of UHS, remarked, “Arab Health is one of the most important global events in the healthcare calendar and we will be making use of this opportunity for us to meet and network with fellow professionals from the healthcare industry to share experience and expertise. The exhibition also represents one of the largest gatherings of healthcare innovators, suppliers, and distributors and we will be leveraging this chance to get a finger on the pulse of the latest developments in the sector to explore new technologies that can expand and further improve the medical services we are proud to offer the people of Sharjah and the UAE.” The UHS CEO went on the comment that in light of the hospital’s rapid growth, UHS was also Michael Stroud Win a Samsung Tab with the Sele Competion alth #arabhe Take a sele at Arab Health and upload it on our social network for your chance to WIN a Samsung Galaxy Tab 3 All at the new 28 Za’abeel Hall 4 facebook.com/arabhealth constantly on the lookout to expand its talent pool and that Arab Health offers a unique opportunity to make direct contact with respected and highly experienced healthcare professionals. “As a leading healthcare provider, we place extremely high value on recruiting and retaining the best medical staff in the region and this is a wonderful chance for us to meet with talented professionals who can add value to our offering”, Stroud added. UHS’ participation in the 2015 edition of Arab Health will mark its debut at the prestigious event and the has taken a 24m2 stand on the concourse, in close proximity to the stand of the Dubai Health Authority, showcasing the hospital’s advanced medical offering, including its groundbreaking programmes such as the Sharjah Breast Centre being run in collaboration with Gustave-Roussy, which is one of the worlds’ leading cancer research institutes and the biggest health centre dedicated to oncology in Europe MONDAY 26 January 2015 get social Get social with us on twitter and facebook using #arabhealth and be in with a chance of featuring on this page tomorrow! Happy tweeting! Kat Trinder @ kattrinder PR I’ll be flying out to Dubai this time next week for @Arab_ Health. Looking forward to putting names to faces on the UK pavilion. #arabhealth Spok EMEA @spok_EMEA Barry Clarke @ Bazisnowindubai Great to see new jobs from locally grown innovators in Northern Ireland. Look forward to seeing #Randox at #ArabHealth @InvestNI_MEast We are looking forward to attending #arabhealth 26-29 January in #Dubai! Plan to visit Spok in hall 1 at stand 1F53 Alfanar @alfanarVIP If you want to go fast, go alone. If you want to go far, go together - African Proverb @heshamoda #Egypt #arabhealth #QOTD Networkexecutive @CNetexc Looking forward to attending the @Arab_Health 2015 Conference #arabhealth #Dubai #conference Hamilton Medical @ hamiltonmedical We are looking forward to meeting you at this year’s Arab Health in Dubai (Booth #S2F50, Saeed Hall). #arabhealth Hiral Chavda @AscomHiralC The first exhibition i’ll be attending in my new role. If you’re visiting #ArabHealth please visit our stand. #newjob Attune Technologies @attunetech Martel Instruments @martel_inst Making the trip to @Arab_Health this January? Our sales manager @ mattpw2013 will be there. Let us know if you will be too. #Arabhealth Tobias Gilk @tobiasgilk Who will be attending #ArabHealth in a few weeks? Please let me know and/or stop by the [email protected] booth PZ C51, and say “Hi”. Can’t wait to meet all the exhibitors, sponsors, delegates and participants at #arabhealth ! 2 weeks to go http://attunelive.com Fahim Qaiser @drfahim Looking forward to see new technologies and companies at #arabhealth 2015 in Dubai. #arabhealth @arab_health 29 Visit us at booths S1D10 and RC10. www.siemens.com/arabhealth Siemens welcomes you to Arab Health 2015 The Middle East is a diverse and rapidly developing region, experiencing a period of sustained economic growth that has resulted in an increasing focus on healthcare investment. Siemens has been a reliable partner to the region for over 150 years and during this time, Siemens has supplied numerous medical imaging and laboratory diagnostics equipment and expertise to many important healthcare projects. This year’s Arab Health exhibition presents a great opportunity for the healthcare industry to convene, share ideas and to exhibit latest innovations. Siemens certainly has much to present at the show, with its wide range of medical imaging and laboratory diagnostics equipment. Visit the Siemens booths at Arab Health this year to learn more. “As a company, Siemens has a record of consistent innovations which is a result of the strong focus we have in R&D, since we understand the demands and necessities faced by healthcare providers today. Our aim is to develop products that can help combat the most pressing health issues of today; to design solutions that enable more informed diagnosis; to make Healthcare more efficient and affordable; and to make the investments of today pay off in the future.” Kay Zwingenberger, Head of Healthcare for the MEA region Answers for life. Please tear off along the perforation. This year’s highlights … … at the Siemens booth S1D10 in Sheikh Saeed Hall 1 02 Surgery Cios Alpha – See the power with Full View FD The first mobile C-arm to use Full View FD technology and the Retina Imaging Chain with IDEAL (Intelligent Dose Efficiency Algorithm) dose reduction: Cios Alpha1 covers the needs of all relevant clinical disciplines, opening up new possibilities in surgical imaging. 01 Women’s Health Mammomat Inspiration PRIME Edition The reference in low-dose mammography. Siemens proudly presents the Mammomat Inspiration PRIME Edition1. Unique PRIME Technology starts a revolution in mammography. It allows for up to 30% less dose and uncompromised image quality2. The new, faster direct-to-digital aSe detector and dose saving algorithms individually calculate the exposure. Get a all-in-one system including Stereotactic Biopsy3 and True 3D Breast Tomosynthesis1,3 which features the industry’s widest angle of 50° for enhanced diagnostic capabilities and new HD Volume Reconstruction for high definition image quality. 1 2 3 1 Cios Alpha is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details. 03 Mobile X-Ray Mobilett Mira Max – Your mobile imaging companion Mobilett Mira Max1 is your mobile imaging companion that lets you bring a broad range of unique MAX advantages to the entire hospital – in a compact, powerful X-ray system that’s always ready to go. The products mentioned are not available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further information. Compared to grid-based acquisition with Mammomat Inspiration, depending on breast thickness. Option 1 Mobilett Mira Max is not commercially available in all countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details. 02 04 03 GALAXY 01 Information Walkway Walkway 05 07 11 09 Meeting 06 06 Refurbished Systems One, two … tree – Your smile for a greener environment 10 08 08 Molecular Imaging Biograph mCT Flow TM and Symbia Intevo™ Would you like to have a tree growing in your name? Take a pic at the RS booth at Arab Health and support the ecoline Green Program. For every picture published on our Wall of Fame (www.siemens.com/1-2-tree), we will plant another tree in Indonesia in your name. 2 1 2 07 Radiation Oncology Imaging Solutions that empower Radiation Therapy. Look closer. See further. Siemens Healthcare provides tailored imaging solutions that help Radiation Therapy professionals to take treatment decisions with confidence. With our comprehensive portfolio – from CT and CT Sliding Gantry, to MR, PET.CT and syngo.via – and our strategic Partnership with Varian, we help advance cancer care. Experience firsthand the clinical results from leading institutions that are leveraging Biograph mCT FlowTM1 and Symbia IntevoTM1 to more confidently diagnose, treat and monitor disease. And see how, together, we are transforming the role of molecular imaging in patient care. Biograph mCT Flow and Symbia Intevo are not commercially available in all countries. Due to regulatory reasons their future availability cannot be guaranteed. Please contact your local Siemens organization for further details. Reading images on tablets is not for diagnostic use. 09 Magnetic Resonance MAGNETOM Amira 1.5T The clever spin on 1.5T: MAGNETOM Amira1 is specifically designed to enhance clinical capabilities and deliver comprehensive, advanced MRI technology. It helps extend care to a greater number of patients, improve the patient experience and boost process efficiency – at lower costs per scan. www.siemens.com/amira 1 The product is currently under development; it is not for sale in the U.S. and other countries. Its future availability cannot be guaranteed. … at the Siemens Medlab booth RC10 in Sheikh Rashid Hall 04 Ultrasound ACUSON X600™ Ultrasound System Discover the New Standard of “Standard.” The ACUSON X600 system is engineered to punch above its price class because some things – such as image quality and reliability – should never be compromised. Its advanced imaging engine, typically reserved for higher-end systems, excels in General Imaging, Cardiology and OB/GYN. 01 ADVIA® Chemistry XPT System1 and ADVIA Centaur® XPT Immunoassay System2 The ADVIA Chemistry XPT System and the ADVIA Centaur XPT Immunoassay System are engineered to provide quality results with continuous operation to meet your laboratory demands. 05 Imaging Software syngo.via – the 3D and advanced visualization software • Simple operations designed to improve workflow • Efficient sample and reagent management for timely and accurate results The new syngo.via1 supports a 360° view for treatment decisions in oncology across modalities, therapies and departments. It comes with a clear new UI and improved Patient Browser. The enhanced syngo.via General Engine provides more anatomical presets, new AutoViews and reporting features. 1 • Seamless connectivity to automation and IT to advance productivity • Intuitive software that is easy to learn and easy to operate 1 2 Due to local regulations, not all products are available in all countries. Not available for sale in the U.S. Due to local regulations, not all products are available in all countries. syngo.via can be used as a standalone device or together with a variety of syngo.via-based software options, which are medical devices in their own right. syngo.via VB10 and the syngo.via VB10 based software options are currently under development, and not for sale in the U.S., China and other countries. Due to regulatory reasons its future availability cannot be guaranteed. Please contact your local Siemens organization for further details. 04 02 Upper deck 01 Ground floor 03 10 Interventional Angiography Artis with PURE®1 Increase your process efficiency in the angio suite, enable all your staff members to get the full potential of the system, and expand your clinical capabilities – with an angio system that combines better ease of use, integrated expert therapy guidance, and tools providing better diagnostic information. 1 02 Xprecia Stride™ Coagulation Analyzer3 03 syngo® Lab Inventory Manager4 The Xprecia Stride™ Coagulation Analyzer was designed specifically to meet the needs of healthcare professionals in usability, safety, efficiency, and accuracy for confidence in point-of-care testing. syngo® Lab Inventory Manager leverages webbased technology and wireless radio frequency identification to enable realtime, automated inventory management and streamlined workflow across multiple laboratories. 3 Not available for sale in the U.S. Product availability varies by country. Artis with PURE® is pending 510(k) clearance, and is not yet commercially available in the United States and other countries. 11 Computed Tomography SOMATOM Definition Edge Improve your institution’s process efficiency and patient outcome by exceeding expectations in all clinical capabilities – from cardiology, to optimized emergency care workflow, and precise therapy response management in oncology. “Exceeding expectations“ VS. “Accepting the average“ Second best is not an option. 4 Under development. Not available for sale. Future availability cannot be guaranteed and may vary by country. 04 Aptio Automation5 Now with a “Tube Inspection Module” and connectivity to the Sysmex® CS-5100 Hemostasis System,6 Aptio™ Automation offers laboratories one unified solution to help them meet expansion and productivity goals. The new “Tube Inspection Module” reduces pre-analytical errors by identifying incorrect tube labeling or loading, and the integration of hemostasis streamlines workflow. 5 6 Product availability varies by country. Not available for sale in the U.S. Sysmex is a trademark of the Sysmex Corporation. www.siemens.com/arabhealth A91XP-9390-A1-7600 Look closer. With a single expert partner in breast ultrasound and mammography you can achieve more than meets the eye. www.siemens.com/ArabHealth Both ultrasound and mammography provide advantages for breast imaging. Combine them and you can reveal even more. See what you can achieve with a single expert partner: Our solutions offer high-quality imaging. They smoothly integrate in your clinical workflows. And they let you access our global service network. So take a closer look! See clearly. Improve results and patient outcomes. Obtain comprehensive clinical information in 2D and 3D. And make more confident decisions, even with dense breast tissue. Simplify operations. Make the most of your team’s resources. Benefit from a consistent user interface, an ergonomic design, and integrated reading solutions throughout breast imaging. For greater efficiency every day. Arab Health Booth #S1D10, Sheikh Saeed Hall 1 Synergize business. Broaden your revenue base and take advantage of a powerful partnership. Offer reliable, consistent, and comprehensive breast imaging services. And substantially increase your competitive edge. Look closer with a single expert partner in breast imaging. Look closer with Siemens. Answers for life. A91CC-9391-A1-7600 www.siemens.com/arabhealth Making healthcare pay off Delivering high-quality diagnostic and interventional services today can be quite a challenge. Yet this is how your performance is measured by your stakeholders every day. Keeping up with latest clinical developments, access to investment funds, finding the right skill sets to staff your teams, standardizing the quality of diagnostic results across teams, efficient processes, reputation building and risk management are many performance dimensions that have been added over time to the core of what you and your teams are tasked to support and deliver: best patient outcome. Scan to find out more about our presence at Arab Health. We at Siemens understand the demands you are facing every day. That’s why we design value-based innovations around you – making each day pay off for your patients and for your business. Visit us at booth S1D10, Sheikh Saeed Hall 1. Answers for life.
© Copyright 2019